Paul McBarron
Director of Finance/CFO presso CYCLACEL PHARMACEUTICALS, INC.
Patrimonio netto: 70 428 $ in data 31/03/2024
Profilo
Paul McBarron is currently the CFO, COO, Secretary & Director at Cyclacel Pharmaceuticals, Inc. He previously worked as the Finance Director & Group Financial Controller at Shire Plc from 1996 to 2001.
He also served as the Director at Scottish Lifesciences Association.
Additionally, he held the position of Chief Operating Officer, Secretary & Executive VP at Cyclacel Group Plc from 2002 to 2008.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
21/12/2023 | 33 378 ( 2.53% ) | 70 428 $ | 31/03/2024 |
Posizioni attive di Paul McBarron
Società | Posizione | Inizio |
---|---|---|
CYCLACEL PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/01/2002 |
Precedenti posizioni note di Paul McBarron
Società | Posizione | Fine |
---|---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Chief Operating Officer | 15/10/2008 |
SHIRE | Director of Finance/CFO | 01/01/2001 |
Scottish Lifesciences Association
Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Scottish Lifesciences Association
Scottish Lifesciences Association Miscellaneous Commercial ServicesCommercial Services The Scottish Lifesciences Association operates an association for life sciences companies and organizations. | Commercial Services |
- Borsa valori
- Insiders
- Paul McBarron